Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.
Tina BhutaniJohn KooJayme HeimNeal BhatiaJacob MathewThomas FerroJ Gabriel VasquezPublished in: Dermatology and therapy (2024)
ClinicalTrials.gov identifier, NCT03718299.